BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kubo N, Araki K, Kuwano H, Shirabe K. Cancer-associated fibroblasts in hepatocellular carcinoma. World J Gastroenterol 2016; 22(30): 6841-6850 [PMID: 27570421 DOI: 10.3748/wjg.v22.i30.6841]
URL: https://www.wjgnet.com/1007-9327/full/v22/i30/6841.htm
Number Citing Articles
1
Chen Han, Yongjie Jiang, Zhaoxia Wang, Hengxiao Wang. Natural killer cells involved in tumour immune escape of hepatocellular carcinomarInternational Immunopharmacology 2019; 73: 10 doi: 10.1016/j.intimp.2019.04.057
2
Xin Jin, Haida Shi, Zhi Li, Huixing Li, Huanxian Ma, Xianjie Shi, Mingjun Zheng. Characterizing PTP4A3/PRL-3 as the Potential Prognostic Marker Gene for Liver Hepatocellular CarcinomaJournal of Oncology 2022; 2022: 1 doi: 10.1155/2022/2717056
3
Difeng Li, Xin Zhang, Lili Jiang. Molecular mechanism and potential therapeutic targets of liver metastasis from gastric cancerFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1000807
4
Leonard Kaps, Detlef Schuppan. Targeting Cancer Associated Fibroblasts in Liver Fibrosis and Liver Cancer Using NanocarriersCells 2020; 9(9): 2027 doi: 10.3390/cells9092027
5
Jun Zhang, Yuliang Pan, Long Jin, Huiyun Yang, Peiguo Cao. Exosomal‐miR‐522‐3p derived from cancer‐associated fibroblasts accelerates tumor metastasis and angiogenesis via repression bone morphogenetic protein 5 in colorectal cancerJournal of Gastroenterology and Hepatology 2024; 39(1): 107 doi: 10.1111/jgh.16345
6
Rui Feng, Yuji Morine, Tetsuya Ikemoto, Satoru Imura, Shuichi Iwahashi, Yu Saito, Mitsuo Shimada. Nab‐paclitaxel interrupts cancer‐stromal interaction through C‐X‐C motif chemokine 10‐mediated interleukin‐6 downregulation in vitroCancer Science 2018; 109(8): 2509 doi: 10.1111/cas.13694
7
Jian Guo, Huating Zeng, Yan Chen. Emerging Nano Drug Delivery Systems Targeting Cancer-Associated Fibroblasts for Improved Antitumor Effect and Tumor Drug PenetrationMolecular Pharmaceutics 2020; 17(4): 1028 doi: 10.1021/acs.molpharmaceut.0c00014
8
Yi-Chang Wang, Yu-Syuan Wu, Chia-Yang Hung, Shao-An Wang, Ming-Jer Young, Tsung-I Hsu, Jan-Jong Hung. USP24 induces IL-6 in tumor-associated microenvironment by stabilizing p300 and β-TrCP and promotes cancer malignancyNature Communications 2018; 9(1) doi: 10.1038/s41467-018-06178-1
9
Shaoshi Zhang, Wendi Bacon, Maikel P. Peppelenbosch, Folkert van Kemenade, Andrew Peter Stubbs. Deciphering Tumour Microenvironment of Liver Cancer through Deconvolution of Bulk RNA-Seq Data with Single-Cell AtlasCancers 2022; 15(1): 153 doi: 10.3390/cancers15010153
10
Hyungjin Rhee, Hye-Young Kim, Ji-Hye Choi, Hyun Goo Woo, Jeong Eun Yoo, Ji Hae Nahm, Jin-Sub Choi, Young Nyun Park. Keratin 19 Expression in Hepatocellular Carcinoma Is Regulated by Fibroblast-Derived HGF via a MET-ERK1/2-AP1 and SP1 AxisCancer Research 2018; 78(7): 1619 doi: 10.1158/0008-5472.CAN-17-0988
11
Hidenori Shiraha, Masaya Iwamuro, Hiroyuki Okada. Tumor MicroenvironmentAdvances in Experimental Medicine and Biology 2020; 1234: 43 doi: 10.1007/978-3-030-37184-5_4
12
Qiang Yuan, Yi Chu, Xiaoyu Li, Yunshu Shi, Yingying Chen, Jimin Zhao, Jing Lu, Kangdong Liu, Yaping Guo. CAFrgDB: a database for cancer-associated fibroblasts related genes and their functions in cancerCancer Gene Therapy 2023; 30(6): 917 doi: 10.1038/s41417-023-00603-4
13
Siming Gong, Changwu Wu, Yingjuan Duan, Juyu Tang, Panfeng Wu. A Comprehensive Pan-Cancer Analysis for Pituitary Tumor-Transforming Gene 1Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.843579
14
Zhong-Yang Jiang, Xi-Mei Ma, Xiao-Hui Luan, Zhen-Yu Liuyang, Yi-Yang Hong, Yuan Dai, Qing-Hua Dong, Guan-Yu Wang. BMI-1 activates hepatic stellate cells to promote the epithelial-mesenchymal transition of colorectal cancer cellsWorld Journal of Gastroenterology 2023; 29(23): 3606-3621 doi: 10.3748/wjg.v29.i23.3606
15
Massimiliano Berretta, Luca Rinaldi, Fabrizio Di Benedetto, Arben Lleshi, Vallì De Re, Gaetano Facchini, Paolo De Paoli, Raffaele Di Francia. Angiogenesis Inhibitors for the Treatment of Hepatocellular CarcinomaFrontiers in Pharmacology 2016; 7 doi: 10.3389/fphar.2016.00428
16
Antonio Sircana, Elena Paschetta, Francesca Saba, Federica Molinaro, Giovanni Musso. Recent Insight into the Role of Fibrosis in Nonalcoholic Steatohepatitis-Related Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2019; 20(7): 1745 doi: 10.3390/ijms20071745
17
Gurbet Celik-Turgut, Nazmiye Olmez, Tugba Koc, Ozden Ozgun-Acar, Asli Semiz, Yavuz Dodurga, Naciye Lale Satiroglu-Tufan, Alaattin Sen. Role of AHR, NF-kB and CYP1A1 crosstalk with the X protein of Hepatitis B virus in hepatocellular carcinoma cellsGene 2023; 853: 147099 doi: 10.1016/j.gene.2022.147099
18
Yiming Shen, Zhengyu Wei, Chongchang Zhou, Jiangping Song, Jianing Wang, Jiada Wang, Linrong Wu, Shenzhe Fang, Zhisen Shen. Arylsulfatase I is a prognostic biomarker for head and neck squamous cell carcinoma and Pan‐cancerJournal of Clinical Laboratory Analysis 2022; 36(9) doi: 10.1002/jcla.24600
19
Xingcheng Xiong, Juanli Xi, Qian Liu, Cixiao Wang, Zeyou Jiang, Su‐Yang Yue, Lei Shi, Yuping Rong, Carmen Berasain. Co‐expression of IL‐7 and PH20 promote anti‐GPC3 CAR‐T tumour suppressor activity in vivo and in vitroLiver International 2021; 41(5): 1033 doi: 10.1111/liv.14771
20
Jacek R. Wilczyński. Interaction of Immune and Cancer CellsExperientia Supplementum 2022; 113: 219 doi: 10.1007/978-3-030-91311-3_8
21
Lushan Peng, Dan Wang, Yingying Han, Tao Huang, Xiaoyun He, Junpu Wang, Chunlin Ou. Emerging Role of Cancer-Associated Fibroblasts-Derived Exosomes in TumorigenesisFrontiers in Immunology 2022; 12 doi: 10.3389/fimmu.2021.795372
22
Yang-Hsiang Lin, Meng-Han Wu, Chau-Ting Yeh, Kwang-Huei Lin. Long Non-Coding RNAs as Mediators of Tumor Microenvironment and Liver Cancer Cell CommunicationInternational Journal of Molecular Sciences 2018; 19(12): 3742 doi: 10.3390/ijms19123742
23
Hamidreza Zalpoor, Fatemeh Aziziyan, Mahsa Liaghat, Maryam Bakhtiyari, Abdullatif Akbari, Mohsen Nabi-Afjadi, Razieh Forghaniesfidvajani, Nima Rezaei. The roles of metabolic profiles and intracellular signaling pathways of tumor microenvironment cells in angiogenesis of solid tumorsCell Communication and Signaling 2022; 20(1) doi: 10.1186/s12964-022-00951-y
24
Longfei Xiao, Zihui Wang, Ning Lu, Huawei Wei, Jian Kang, Mengyi Yuan, Xihui Sheng, Xiaolong Qi, Kai Xing, Yong Guo, Xiangguo Wang, Junjin Zhao, Yuping Gao, Hemin Ni. Dihydrotestosterone through blockade of TGF-β/Smad signaling mediates the anti-fibrosis effect under hypoxia in canine Sertoli cellsThe Journal of Steroid Biochemistry and Molecular Biology 2022; 216: 106041 doi: 10.1016/j.jsbmb.2021.106041
25
Ka‐Hei Lam, Stephanie Ma. Noncellular components in the liver cancer stem cell niche: Biology and potential clinical implicationsHepatology 2023; 78(3): 991 doi: 10.1002/hep.32629
26
Xian Zhong, Haiyi Long, Lili Chen, Yuhua Xie, Yifan Shi, Jianyun Peng, Ruiying Zheng, Liya Su, Yu Duan, Xiaoyan Xie, Manxia Lin. Stiffness on shear wave elastography as a potential microenvironment biomarker for predicting tumor recurrence in HBV-related hepatocellular carcinomaInsights into Imaging 2023; 14(1) doi: 10.1186/s13244-023-01505-7
27
Antonella Argentiero, Antonella Delvecchio, Rossella Fasano, Alessandro Andriano, Ingrid Catalina Caradonna, Riccardo Memeo, Vanessa Desantis. The Complexity of the Tumor Microenvironment in Hepatocellular Carcinoma and Emerging Therapeutic DevelopmentsJournal of Clinical Medicine 2023; 12(23): 7469 doi: 10.3390/jcm12237469
28
Srinivas Pittala, Yakov Krelin, Varda Shoshan-Barmatz. Targeting Liver Cancer and Associated Pathologies in Mice with a Mitochondrial VDAC1-Based PeptideNeoplasia 2018; 20(6): 594 doi: 10.1016/j.neo.2018.02.012
29
Fuat Bicer, Catrina Kure, Anil A. Ozluk, Bassel F. El-Rayes, Mehmet Akce. Advances in Immunotherapy for Hepatocellular Carcinoma (HCC)Current Oncology 2023; 30(11): 9789 doi: 10.3390/curroncol30110711
30
Qingyu Cui, Bixiao Wang, Kaifu Li, Haichen Sun, Tao Hai, Yan Zhang, Hua Kang. Upregulating MMP‑1 in carcinoma‑associated fibroblasts reduces the efficacy of Taxotere on breast cancer synergized by Collagen IVOncology Letters 2018;  doi: 10.3892/ol.2018.9092
31
Zeli Yin, Chengyong Dong, Keqiu Jiang, Zhe Xu, Rui Li, Kun Guo, Shujuan Shao, Liming Wang. Heterogeneity of cancer-associated fibroblasts and roles in the progression, prognosis, and therapy of hepatocellular carcinomaJournal of Hematology & Oncology 2019; 12(1) doi: 10.1186/s13045-019-0782-x
32
Bita Mahdavi Firouzabadi, Maria Rosa Gigliobianco, Joice Maria Joseph, Roberta Censi, Piera Di Martino. Design of Nanoparticles in Cancer Therapy Based on Tumor Microenvironment PropertiesPharmaceutics 2022; 14(12): 2708 doi: 10.3390/pharmaceutics14122708
33
Jianfei Tu, Xihui Ying, Dengke Zhang, Qiaoyou Weng, Weibo Mao, Li Chen, Xulu Wu, Chaoyong Tu, Jiansong Ji, Yuan Huang. High expression of angiogenic factor AGGF1 is an independent prognostic factor for hepatocellular carcinomaOncotarget 2017; 8(67): 111623 doi: 10.18632/oncotarget.22880
34
Xiang Zhang, Qingqing Xiao, Cong Zhang, Qinghua Zhou, Tao Xu. Construction of a prognostic model with CAFs for predicting the prognosis and immunotherapeutic response of lung squamous cell carcinomaJournal of Cellular and Molecular Medicine 2024; 28(8) doi: 10.1111/jcmm.18262
35
Shinya Mizuno, Eriko Osaki. Liver Diseases2020; : 65 doi: 10.1007/978-3-030-24432-3_6
36
Emil Novruzov, Yuriko Mori, Fuad Novruzov. The Diagnostic Value of Fibroblast Activation Protein Imaging in Hepatocellular Carcinoma and Cholangiocellular CarcinomaPET Clinics 2023; 18(3): 309 doi: 10.1016/j.cpet.2023.02.011
37
Kumar Jayant, Nagy Habib, Kai W. Huang, Jane Warwick, Ramesh Arasaradnam. Recent Advances: The Imbalance of Immune Cells and Cytokines in the Pathogenesis of Hepatocellular CarcinomaDiagnostics 2020; 10(5): 338 doi: 10.3390/diagnostics10050338
38
Asmaa F. Khafaga, Shaker A. Mousa, Lotfi Aleya, Mohamed M. Abdel-Daim. Three-dimensional (3D) cell culture: a valuable step in advancing treatments for human hepatocellular carcinomaCancer Cell International 2022; 22(1) doi: 10.1186/s12935-022-02662-3
39
Weijie Deng, Peng Zhu, Huixuan Xu, Xianliang Hou, Wenbiao Chen, Zhiqian Zhang. Classification and Prognostic Characteristics of Hepatocellular Carcinoma Based on Glycolysis Cholesterol Synthesis AxisJournal of Oncology 2022; 2022: 1 doi: 10.1155/2022/2014625
40
Norihiro Ishii, Kenichiro Araki, Takehiko Yokobori, Kei Hagiwara, Dorgormaa Gantumur, Takahiro Yamanaka, Tadashi Handa, Mariko Tsukagoshi, Takamichi Igarashi, Akira Watanabe, Norio Kubo, Norifumi Harimoto, Atsushi Masamune, Kazuo Umezawa, Hiroyuki Kuwano, Ken Shirabe. Conophylline suppresses pancreatic cancer desmoplasia and cancer‐promoting cytokines produced by cancer‐associated fibroblastsCancer Science 2019; 110(1): 334 doi: 10.1111/cas.13847
41
Siqi Chen, Yaqing Du, Xin-Yuan Guan, Qian Yan. The current status of tumor microenvironment and cancer stem cells in sorafenib resistance of hepatocellular carcinomaFrontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1204513
42
Sanghwa Kim, Su-Yeon Lee, Haeng Ran Seo. Deciphering the underlying mechanism of liver diseases through utilization of multicellular hepatic spheroid modelsBMB Reports 2023; 56(4): 225 doi: 10.5483/BMBRep.2023-0010
43
Devis Pascut, Muhammad Yogi Pratama, Niem V.T. Vo, Rina Masadah, Claudio Tiribelli. The Crosstalk between Tumor Cells and the Microenvironment in Hepatocellular Carcinoma: The Role of Exosomal microRNAs and Their Clinical ImplicationsCancers 2020; 12(4): 823 doi: 10.3390/cancers12040823
44
Lotte D. de Hosson, Tim J. Takkenkamp, Gursah Kats-Ugurlu, Grietje Bouma, Marian Bulthuis, Elisabeth G. E. de Vries, Martijn van Faassen, Ido P. Kema, Annemiek M. E. Walenkamp. Neuroendocrine tumours and their microenvironmentCancer Immunology, Immunotherapy 2020; 69(8): 1449 doi: 10.1007/s00262-020-02556-1
45
Takahiro Kubo, Norihisa Nishimura, Kosuke Kaji, Fumimasa Tomooka, Akihiko Shibamoto, Satoshi Iwai, Junya Suzuki, Hideto Kawaratani, Tadashi Namisaki, Takemi Akahane, Hitoshi Yoshiji. Role of Epiregulin on Lipopolysaccharide-Induced Hepatocarcinogenesis as a Mediator via EGFR Signaling in the Cancer MicroenvironmentInternational Journal of Molecular Sciences 2024; 25(8): 4405 doi: 10.3390/ijms25084405
46
Nilu Dhungel, Reneau Youngblood, Min Chu, Jennifer Carroll, Ana-Maria Dragoi. Assessing the epithelial-to-mesenchymal plasticity in a small cell lung carcinoma (SCLC) and lung fibroblasts co-culture modelFrontiers in Molecular Biosciences 2023; 10 doi: 10.3389/fmolb.2023.1096326
47
Bin Huang, Manping Huang, Qin Li. Cancer-Associated Fibroblasts Promote Angiogenesis of Hepatocellular Carcinoma by VEGF-Mediated EZH2/VASH1 PathwayTechnology in Cancer Research & Treatment 2019; 18: 153303381987990 doi: 10.1177/1533033819879905
48
Yang Bai, Liangdong Li, Jun Li, Xin Lu. Association analysis of FXYD5 with prognosis and immunological characteristics across pan-cancerHeliyon 2024; 10(9): e30727 doi: 10.1016/j.heliyon.2024.e30727
49
Natasha Zulaziz, San Jiun Chai, Kue Peng Lim. The origins, roles and therapies of cancer associated fibroblast in liver cancerFrontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1151373
50
Jelena Radić, Bojana Kožik, Ivan Nikolić, Ivana Kolarov-Bjelobrk, Tijana Vasiljević, Bojana Vranjković, Sanja Despotović. Multiple Roles of LOXL2 in the Progression of Hepatocellular Carcinoma and Its Potential for Therapeutic TargetingInternational Journal of Molecular Sciences 2023; 24(14): 11745 doi: 10.3390/ijms241411745
51
Isabel Fabregat, Daniel Caballero-Díaz. Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and HepatocarcinogenesisFrontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00357
52
Madelyn Miller, Shadab A. Siddiqi. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 32022; : 377 doi: 10.1016/B978-0-323-99283-1.00008-2
53
Changbiao Li, Xiao Xu. Biological functions and clinical applications of exosomal non-coding RNAs in hepatocellular carcinomaCellular and Molecular Life Sciences 2019; 76(21): 4203 doi: 10.1007/s00018-019-03215-0
54
Baowei Lv, Wenyan Zhu, Chunqing Feng. Coptisine Blocks Secretion of Exosomal circCCT3 from Cancer-Associated Fibroblasts to Reprogram Glucose Metabolism in Hepatocellular CarcinomaDNA and Cell Biology 2020; 39(12): 2281 doi: 10.1089/dna.2020.6058
55
Jiaqian Han, Xiaobo Xu, Zi Liu, Zengqiang Li, Yingliang Wu, Daiying Zuo. Recent advances of molecular mechanisms of regulating PD-L1 expression in melanomaInternational Immunopharmacology 2020; 88: 106971 doi: 10.1016/j.intimp.2020.106971
56
Francesco Dituri, Matteo Centonze, Erwin J. W. Berenschot, Niels R. Tas, Arturo Susarrey-Arce, Silke Krol. Complex Tumor Spheroid Formation and One-Step Cancer-Associated Fibroblasts Purification from Hepatocellular Carcinoma Tissue Promoted by Inorganic Surface TopographyNanomaterials 2021; 11(12): 3233 doi: 10.3390/nano11123233
57
Junki Maehara, Yohei Masugi, Tokiya Abe, Hanako Tsujikawa, Yutaka Kurebayashi, Akihisa Ueno, Hidenori Ojima, Shigeo Okuda, Masahiro Jinzaki, Masahiro Shinoda, Yuko Kitagawa, Yoshinao Oda, Hiroshi Honda, Michiie Sakamoto. Quantification of intratumoral collagen and elastin fibers within hepatocellular carcinoma tissues finds correlations with clinico‐patho‐radiological featuresHepatology Research 2020; 50(5): 607 doi: 10.1111/hepr.13484
58
Vito Longo, Oronzo Brunetti, Antonio Gnoni, Antonella Licchetta, Sabina Delcuratolo, Riccardo Memeo, Antonio Giovanni Solimando, Antonella Argentiero. Emerging Role of Immune Checkpoint Inhibitors in Hepatocellular CarcinomaMedicina 2019; 55(10): 698 doi: 10.3390/medicina55100698
59
Xiaocheng Zhou, Tinglin Yan, Chunming Huang, Zhi Xu, Lin Wang, Erhui Jiang, Hui Wang, Yang Chen, Ke Liu, Zhe Shao, Zhengjun Shang. Melanoma cell-secreted exosomal miR-155-5p induce proangiogenic switch of cancer-associated fibroblasts via SOCS1/JAK2/STAT3 signaling pathwayJournal of Experimental & Clinical Cancer Research 2018; 37(1) doi: 10.1186/s13046-018-0911-3
60
Italia Falcone, Fabiana Conciatori, Chiara Bazzichetto, Gianluigi Ferretti, Francesco Cognetti, Ludovica Ciuffreda, Michele Milella. Tumor Microenvironment: Implications in Melanoma Resistance to Targeted Therapy and ImmunotherapyCancers 2020; 12(10): 2870 doi: 10.3390/cancers12102870
61
Nesil Yalman. LMCD1 antisense RNA 1 is a newly identified long noncoding RNAAnti-Cancer Drugs 2022; 33(1): 1 doi: 10.1097/CAD.0000000000001124
62
Yanying Li, Jingliang Wu, Qiao Lu, Xuemin Liu, Jiaxuan Wen, Xiaohui Qi, Jianhao Liu, Bo Lian, Bo Zhang, Hengyi Sun, Guixiang Tian. GA&HA-Modified Liposomes for Co-Delivery of Aprepitant and Curcumin to Inhibit Drug-Resistance and Metastasis of Hepatocellular CarcinomaInternational Journal of Nanomedicine 2022; : 2559 doi: 10.2147/IJN.S366180
63
Yuanzhen Sun, Xiaoli Fan, Qing Zhang, Xiaoyu Shi, Guangwei Xu, Cuimin Zou. Cancer-associated fibroblasts secrete FGF-1 to promote ovarian proliferation, migration, and invasion through the activation of FGF-1/FGFR4 signalingTumor Biology 2017; 39(7): 101042831771259 doi: 10.1177/1010428317712592
64
Yun-Hong Xia, Zhen Lu, Min Zhao, Wen-Ting Dai, Lu Ding, Li-Xia Hu, Guo-Lin Jiang. Tumor-specific hepatic stellate cells (tHSCs) induces DIgR2 expression in dendritic cells to inhibit T cellsOncotarget 2017; 8(33): 55084 doi: 10.18632/oncotarget.19027
65
Shuo Wang, Peng Du, Yudong Cao, Jinchao Ma, Xiao Yang, Ziyi Yu, Yong Yang. Cancer associated fibroblasts secreted exosomal miR-1290 contributes to prostate cancer cell growth and metastasis via targeting GSK3βCell Death Discovery 2022; 8(1) doi: 10.1038/s41420-022-01163-6
66
Bao-Min Shi, Wen Lu, Kun Ji, Yu-Feng Wang, Shuai Xiao, Xiu-Yan Wang. Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinomaWorld Journal of Gastroenterology 2017; 23(20): 3713-3720 doi: 10.3748/wjg.v23.i20.3713
67
Qiong Wang, Yu‐Chao Zhang, Li‐Fang Zhu, Lu Pan, Miao Yu, Wei‐Li Shen, Bang Li, Wei Zhang, Lai‐Kui Liu. Heat shock factor 1 in cancer‐associated fibroblasts is a potential prognostic factor and drives progression of oral squamous cell carcinomaCancer Science 2019; 110(5): 1790 doi: 10.1111/cas.13991
68
Jianming Hu, Leyi Zhang, Wuzhen Chen, Lesang Shen, Jingxin Jiang, Shanshan Sun, Zhigang Chen. Role of Intra- and Extracellular Lipid Signals in Cancer Stemness and Potential Therapeutic StrategyFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.730751
69
Anh Tuan Nguyen, Joanne Chia, Manon Ros, Kam Man Hui, Frederic Saltel, Frederic Bard. Organelle Specific O-Glycosylation Drives MMP14 Activation, Tumor Growth, and MetastasisCancer Cell 2017; 32(5): 639 doi: 10.1016/j.ccell.2017.10.001
70
Lawrence M Agius. Dimensions of Niche-Induced Anti-Apoptosis of Therapeutically Resistant Neoplasms in Radio-Chemo-TherapyInternational Journal of Radiology & Radiation Therapy 2017; 2(3) doi: 10.15406/ijrrt.2017.02.00026
71
Massimiliano Cadamuro, Giorgia Nuozzi, Paolo Simioni, Luca Fabris. The tumor microenvironment in hepatocarcinoma: dissecting the functions of cancer-associated fibroblastsHepatoma Research 2023;  doi: 10.20517/2394-5079.2023.94
72
Jeannette Huaman, Cuong Bach, Adeodat Ilboudo, Olorunseun O. Ogunwobi. Precision Molecular Pathology of Liver CancerMolecular Pathology Library 2018; : 131 doi: 10.1007/978-3-319-68082-8_8
73
Wenge Dong, Yangyang Xie, Hai Huang. Prognostic Value of Cancer-Associated Fibroblast-Related Gene Signatures in Hepatocellular CarcinomaFrontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.884777
74
Yongfang Wang, Hanyun Liang, Jie Zheng. Exosomal microRNAs mediating crosstalk between cancer cells and cancer-associated fibroblasts in the tumor microenvironmentPathology - Research and Practice 2022; 239: 154159 doi: 10.1016/j.prp.2022.154159
75
Ning Zhang, Long-Rong Wang, Dou-Dou Li, De-Ning Ma, Cheng-Hao Wang, Xi-Gan He, Dong-Mei Gao, Lu Wang, Zhao-You Tang. Interferon-α Combined With Herbal Compound “Songyou Yin” Effectively Inhibits the Increased Invasiveness and Metastasis by Insufficient Radiofrequency Ablation of Hepatocellular Carcinoma in an Animal ModelIntegrative Cancer Therapies 2018; 17(4): 1260 doi: 10.1177/1534735418801525
76
Fugen Takagi, Motomasa Furuse, Hiroko Kuwabara, Akihiro Kambara, Naoki Omura, Shogo Tanabe, Ryokichi Yagi, Ryo Hiramatsu, Masahiro Kameda, Naosuke Nonoguchi, Shinji Kawabata, Toshihiro Takami, Shin‐Ichi Miyatake, Masahiko Wanibuchi. Expression and distribution of hypoxia‐inducible factor‐1α and vascular endothelial growth factor in comparison between radiation necrosis and tumor tissue in metastatic brain tumor: A case reportNeuropathology 2023;  doi: 10.1111/neup.12958
77
Chun-Feng Xie, Kun-Liang Feng, Ji-Nan Wang, Rui Luo, Chong-Kai Fang, Ying Zhang, Chuang-Peng Shen, Chong Zhong. Jianpi Huayu decoction inhibits the epithelial–mesenchymal transition of hepatocellular carcinoma cells by suppressing exosomal miR-23a-3p/Smad signalingJournal of Ethnopharmacology 2022; 294: 115360 doi: 10.1016/j.jep.2022.115360
78
Jie Zhang, Chaoyu Gu, Qianqian Song, Mengqi Zhu, Yuqing Xu, Mingbing Xiao, Wenjie Zheng. Identifying cancer-associated fibroblasts as emerging targets for hepatocellular carcinomaCell & Bioscience 2020; 10(1) doi: 10.1186/s13578-020-00488-y
79
Melissa Borgia, Michele Dal Bo, Giuseppe Toffoli. Role of Virus-Related Chronic Inflammation and Mechanisms of Cancer Immune-Suppression in Pathogenesis and Progression of Hepatocellular CarcinomaCancers 2021; 13(17): 4387 doi: 10.3390/cancers13174387
80
Wei Li, Qiang Fu, Wenling Man, Huanqing Guo, Po Yang. LncRNA OR3A4 participates in the angiogenesis of hepatocellular carcinoma through modulating AGGF1/akt/mTOR pathwayEuropean Journal of Pharmacology 2019; 849: 106 doi: 10.1016/j.ejphar.2019.01.049
81
Avijit Paul, Yakov Krelin, Tasleem Arif, Rina Jeger, Varda Shoshan-Barmatz. A New Role for the Mitochondrial Pro-apoptotic Protein SMAC/Diablo in Phospholipid Synthesis Associated with TumorigenesisMolecular Therapy 2018; 26(3): 680 doi: 10.1016/j.ymthe.2017.12.020
82
Yuting Gao, Yi Gong, Junlan Lu, Huiqin Hao, Xinli Shi. Targeting YAP1 to improve the efficacy of immune checkpoint inhibitors in liver cancer: mechanism and strategyFrontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1377722
83
Jie Zhao, Shaobo Yang, Caihong Lv, Ying Liu. Cancer-associated fibroblasts suppressed ferroptosis in glioblastoma via upregulating lncRNA DLEU1American Journal of Physiology-Cell Physiology 2023; 324(5): C1039 doi: 10.1152/ajpcell.00454.2022
84
Qing Li, Chun-Chao Zhu, Bo Ni, Zi-Zhen Zhang, Shu-Heng Jiang, Li-Peng Hu, Xu Wang, Xiao-Xin Zhang, Pei-Qi Huang, Qin Yang, Jun Li, Jian-Ren Gu, Jia Xu, Kathy Qian Luo, Gang Zhao, Zhi-Gang Zhang. Lysyl oxidase promotes liver metastasis of gastric cancer via facilitating the reciprocal interactions between tumor cells and cancer associated fibroblastseBioMedicine 2019; 49: 157 doi: 10.1016/j.ebiom.2019.10.037
85
Hiroyuki Kuwano, Takehiko Yokobori, Tatsuya Miyazaki, Makoto Sohda, Tomonori Yoshida, Yoko Azuma, Hironori Tatsuki, Yasunari Ubukata, Nobuhiro Nakazawa, Kengo Kuriyama, Akihiko Sano, Makoto Sakai, Hiroomi Ogawa, Hiroshi Saeki, Ken Shirabe. Field carcinogenesis and biological significance of the potential of the bystander effect: carcinogenesis, therapeutic response, and tissue regenerationSurgery Today 2023; 53(5): 545 doi: 10.1007/s00595-022-02524-5
86
Hao Wang, Wenwei Zhu, Shuhua Ren, Yanyan Kong, Qi Huang, Jun Zhao, Yihui Guan, Huliang Jia, Jinhong Chen, Lu Lu, Fang Xie, Lunxiu Qin. 68Ga-FAPI-04 Versus 18F-FDG PET/CT in the Detection of Hepatocellular CarcinomaFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.693640
87
Thuc Ly, Gunjan Gaur, Sufi Mary Thomas. Autophagy and Metabolism2022; : 163 doi: 10.1016/B978-0-323-99879-6.00004-3
88
Xian Zhong, Lili Chen, Haiyi Long, Ruiying Zheng, Liya Su, Yu Duan, Xiaoyan Xie, Manxia Lin. The “stiff rim” sign of hepatocellular carcinoma on shear wave elastography: correlation with pathological features and potential prognostic valueAbdominal Radiology 2022; 47(12): 4115 doi: 10.1007/s00261-022-03628-9
89
Francesco Dituri, Serena Mancarella, Grazia Serino, Nada Chaoul, Luigi Giovanni Lupo, Erica Villa, Isabel Fabregat, Gianluigi Giannelli. Direct and Indirect Effect of TGFβ on Treg Transendothelial Recruitment in HCC Tissue MicroenvironmentInternational Journal of Molecular Sciences 2021; 22(21): 11765 doi: 10.3390/ijms222111765
90
Jung Woo Eun, Jung Hwan Yoon, Hye Ri Ahn, Seokhwi Kim, Young Bae Kim, Su Bin Lim, Won Park, Tae Wook Kang, Geum Ok Baek, Moon Gyeong Yoon, Ju A Son, Ji Hyang Weon, Soon Sun Kim, Hyo Jung Cho, Jae Youn Cheong. Cancer‐associated fibroblast‐derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinibCancer Communications 2023; 43(4): 455 doi: 10.1002/cac2.12414
91
Jacek R Wilczyński, Miłosz Wilczyński, Edyta Paradowska. Cancer Stem Cells in Ovarian Cancer—A Source of Tumor Success and a Challenging Target for Novel TherapiesInternational Journal of Molecular Sciences 2022; 23(5): 2496 doi: 10.3390/ijms23052496
92
Samantha M. Ruff, Timothy M. Pawlik. Emerging therapies targeting growth factors in hepatocellular carcinomaExpert Opinion on Pharmacotherapy 2024; 25(3): 255 doi: 10.1080/14656566.2024.2340714
93
Wen-Qi Zhang, Jia-Xin Sun, Shu-Ting Lan, Xiao-Mei Sun, Yi-Jing Guo, Bi-Chao Wen, Jie Chen, Gang Liu. Regulation of Fuzheng Huayu capsule on inhibiting the fibrosis-associated hepatocellular carcinogenesisJournal of Asian Natural Products Research 2024; : 1 doi: 10.1080/10286020.2024.2355132
94
Yunbin Zhang, Jiang Xu, Ning Zhang, Ming Chen, Hua Wang, Di Zhu. Targeting the tumour immune microenvironment for cancer therapy in human gastrointestinal malignanciesCancer Letters 2019; 458: 123 doi: 10.1016/j.canlet.2019.05.017
95
Man Yao, Shufang Liang, Binbin Cheng. Role of exosomes in hepatocellular carcinoma and the regulation of traditional Chinese medicineFrontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1110922
96
Radwa Ayman Salah, Mohamed A. Nasr, Azza M. El-Derby, M. Abd Elkodous, Rania Hassan Mohamed, Nada El-Ekiaby, Aya Osama, Shimaa E. Elshenawy, Merna Hatem Mohamed Hamad, Sameh Magdeldin, Mahmoud M. Gabr, Ahmed I. Abdelaziz, Nagwa S. El-Badri. Hepatocellular carcinoma cell line-microenvironment induced cancer-associated phenotype, genotype and functionality in mesenchymal stem cellsLife Sciences 2022; 288: 120168 doi: 10.1016/j.lfs.2021.120168
97
James B. McCarthy, Dorraya El-Ashry, Eva A. Turley. Hyaluronan, Cancer-Associated Fibroblasts and the Tumor Microenvironment in Malignant ProgressionFrontiers in Cell and Developmental Biology 2018; 6 doi: 10.3389/fcell.2018.00048
98
Hyungjin Rhee, Taek Chung, Jeong Eun Yoo, Ji Hae Nahm, Ha Young Woo, Gi Hong Choi, Dai Hoon Han, Young Nyun Park. Gross type of hepatocellular carcinoma reflects the tumor hypoxia, fibrosis, and stemness-related marker expressionHepatology International 2020; 14(2): 239 doi: 10.1007/s12072-020-10012-6
99
Xiaobo Zheng, Peng Wang, Li Li, Jing Yu, Chune Yu, Liangliang Xu, Lian Li, Fuzhen Dai, Lei Feng, Hong Zou, Xiaobo Chen, Ming Zhang, Mingqing Xu. Cancer-Associated Fibroblasts Promote Vascular Invasion of Hepatocellular Carcinoma via Downregulating Decorin-integrin β1 SignalingFrontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.678670
100
Shaoping She, Liying Ren, Pu Chen, Mingyang Wang, Dongbo Chen, Ying Wang, Hongsong Chen. Functional Roles of Chemokine Receptor CCR2 and Its Ligands in Liver DiseaseFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.812431
101
Amanda J. Craig, Johann von Felden, Teresa Garcia-Lezana, Samantha Sarcognato, Augusto Villanueva. Tumour evolution in hepatocellular carcinomaNature Reviews Gastroenterology & Hepatology 2020; 17(3): 139 doi: 10.1038/s41575-019-0229-4
102
Wei Jing, Ruoyu Peng, Xiaogai Li, Shaogang Lv, Yu Duan, Shitao Jiang, Fu Wang. Study on the Prognostic Values of TTC36 Correlated with Immune Infiltrates and Its Methylation in Hepatocellular CarcinomaJournal of Immunology Research 2022; 2022: 1 doi: 10.1155/2022/7267131
103
Wenqi Shen, Ping-an Yao, Wenjing Li, Changji Gu, Tian Gao, Yi Cao, Zheng Wang, Renjun Pei, Chungen Xing. Cancer-associated fibroblast-targeted nanodrugs reshape colorectal tumor microenvironments to suppress tumor proliferation, metastasis and improve drug penetrationJournal of Materials Chemistry B 2023; 11(9): 1871 doi: 10.1039/D2TB02253B
104
Yang Liu, Xi Zhang, Junjun Zhang, Juan Tan, Jie Li, Zewen Song. Development and Validation of a Combined Ferroptosis and Immune Prognostic Classifier for Hepatocellular CarcinomaFrontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.596679
105
Alba Herrero, Elisabeth Knetemann, Inge Mannaerts. Review: Challenges of In Vitro CAF Modelling in Liver CancersCancers 2021; 13(23): 5914 doi: 10.3390/cancers13235914
106
Chao Li, Adilson Fonseca Teixeira, Hong-Jian Zhu, Peter ten Dijke. Cancer associated-fibroblast-derived exosomes in cancer progressionMolecular Cancer 2021; 20(1) doi: 10.1186/s12943-021-01463-y
107
Paul J. Wrighton, Isaac M. Oderberg, Wolfram Goessling. There Is Something Fishy About Liver Cancer: Zebrafish Models of Hepatocellular CarcinomaCellular and Molecular Gastroenterology and Hepatology 2019; 8(3): 347 doi: 10.1016/j.jcmgh.2019.05.002
108
Yuanfei Lu, Na Feng, Yongzhong Du, Risheng Yu. Nanoparticle-Based Therapeutics to Overcome Obstacles in the Tumor Microenvironment of Hepatocellular CarcinomaNanomaterials 2022; 12(16): 2832 doi: 10.3390/nano12162832
109
Austin Cook, Shadab A. Siddiqi. Phytochemicals Targeting Tumor Microenvironment in Gastrointestinal Cancers2020; : 303 doi: 10.1007/978-3-030-48405-7_14
110
Takahiro Yamanaka, Norifumi Harimoto, Takehiko Yokobori, Ryo Muranushi, Kouki Hoshino, Kei Hagiwara, Dolgormaa Gantumur, Tadashi Handa, Norihiro Ishii, Mariko Tsukagoshi, Takamichi Igarashi, Akira Watanabe, Norio Kubo, Kenichiro Araki, Kazuo Umezawa, Ken Shirabe. Conophylline Inhibits Hepatocellular Carcinoma by Inhibiting Activated Cancer-associated Fibroblasts Through Suppression of G Protein–coupled Receptor 68Molecular Cancer Therapeutics 2021; 20(6): 1019 doi: 10.1158/1535-7163.MCT-20-0150
111
Xiang Li, Erhui Jiang, Hui Zhao, Yang Chen, Yuming Xu, Chunyu Feng, Ji Li, Zhengjun Shang. Glycometabolic reprogramming-mediated proangiogenic phenotype enhancement of cancer-associated fibroblasts in oral squamous cell carcinoma: role of PGC-1α/PFKFB3 axisBritish Journal of Cancer 2022; 127(3): 449 doi: 10.1038/s41416-022-01818-2
112
Guixiong Zhang, Yitai Xiao, Xiaokai Zhang, Wenzhe Fan, Yue Zhao, Yanqin Wu, Hongyu Wang, Jiaping Li. Dissecting a hypoxia-related angiogenic gene signature for predicting prognosis and immune status in hepatocellular carcinomaFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.978050
113
Nyanbol Kuol, Lily Stojanovska, Kulmira Nurgali, Vasso Apostolopoulos. The mechanisms tumor cells utilize to evade the host's immune systemMaturitas 2017; 105: 8 doi: 10.1016/j.maturitas.2017.04.014
114
Margaux Sala, Manon Ros, Frédéric Saltel. A Complex and Evolutive Character: Two Face Aspects of ECM in Tumor ProgressionFrontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01620
115
Shika Hanif Malgundkar, Yahya Tamimi. Exosomes as Crucial Emerging Tools for Intercellular Communication with Therapeutic Potential in Ovarian CancerFuture Science OA 2023; 9(1) doi: 10.2144/fsoa-2022-0032
116
Zeli Yin, Keqiu Jiang, Rui Li, Chengyong Dong, Liming Wang. Multipotent mesenchymal stromal cells play critical roles in hepatocellular carcinoma initiation, progression and therapyMolecular Cancer 2018; 17(1) doi: 10.1186/s12943-018-0926-6
117
Atsunori Tsuchiya, Masahiro Ogawa, Takayuki Watanabe, Suguru Takeuchi, Yuichi Kojima, Yusuke Watanabe, Naruhiro Kimura, Kazunao Hayashi, Junji Yokoyama, Shuji Terai. Diverse perspectives to address for the future treatment of heterogeneous hepatocellular carcinomaHeliyon 2019; 5(3): e01325 doi: 10.1016/j.heliyon.2019.e01325
118
Yuan Zhou, Haozhen Ren, Bo Dai, Jun Li, Longcheng Shang, Jianfei Huang, Xiaolei Shi. Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblastsJournal of Experimental & Clinical Cancer Research 2018; 37(1) doi: 10.1186/s13046-018-0965-2
119
Irmak Ayvaz, Dilara Sunay, Ece Sariyar, Esra Erdal, Zeynep Firtina Karagonlar. Three-Dimensional Cell Culture Models of Hepatocellular Carcinoma — a ReviewJournal of Gastrointestinal Cancer 2021; 52(4): 1294 doi: 10.1007/s12029-021-00772-1
120
Meng Zhang, Junlong Zhu, Pan Zhang, Lingxun Li, Min Min, Tinghao Li, Weiyang He. Development and validation of cancer-associated fibroblasts-related gene landscape in prognosis and immune microenvironment of bladder cancerFrontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1174252
121
Hongjin Wang, Nian Wang, Ze Tang, Qiuyu Liu, Shiyu Nie, Wu Tao. An 8-gene predicting survival model of hepatocellular carcinoma (HCC) related to pyroptosis and cuproptosisHereditas 2023; 160(1) doi: 10.1186/s41065-023-00288-7
122
Zhen Lu, Yun-Hong Xia, Min Zhao, Bing Zhang, Wen-Ting Dai, Lu Ding, Li-Xia Hu, Jin-Ling Bi, Guo-Lin Jiang. DlgR2 knockdown boosts dendritic cell activity and inhibits hepatocellular carcinoma tumor in-situ growthOncotarget 2017; 8(33): 54993 doi: 10.18632/oncotarget.18990
123
Dashuai Yang, Yang Su, Fangrui Zhao, Chen Chen, Kailiang Zhao, Xiangyun Xiong, Youming Ding. A Practical Nomogram and Risk Stratification System Predicting Cancer-Specific Survival for Hepatocellular Carcinoma Patients With Severe Liver FibrosisFrontiers in Surgery 2022; 9 doi: 10.3389/fsurg.2022.920589
124
Srija Chakraborty, Thomas J. DePalma, Aleksander Skardal. Increasing Accuracy of In Vitro Cancer Models: Engineering Stromal Complexity into Tumor Organoid PlatformsAdvanced NanoBiomed Research 2021; 1(12) doi: 10.1002/anbr.202100061
125
Iftikhar Ali Khawar, Jong Kook Park, Eun Sun Jung, Myung Ah Lee, Suhwan Chang, Hyo-Jeong Kuh. Three Dimensional Mixed-Cell Spheroids Mimic Stroma-Mediated Chemoresistance and Invasive Migration in hepatocellular carcinomaNeoplasia 2018; 20(8): 800 doi: 10.1016/j.neo.2018.05.008
126
Kevin Dzobo, Collet Dandara. Broadening Drug Design and Targets to Tumor Microenvironment? Cancer-Associated Fibroblast Marker Expression in Cancers and Relevance for Survival OutcomesOMICS: A Journal of Integrative Biology 2020; 24(6): 340 doi: 10.1089/omi.2020.0042
127
Muyue Yang, Jipeng Li, Ping Gu, Xianqun Fan. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironmentBioactive Materials 2021; 6(7): 1973 doi: 10.1016/j.bioactmat.2020.12.010